MSN: Less than 1 percent of clinical trials include trans patients
Information about this website: Following the March 2026 merger of Patient Advocate Foundation and the PAN Foundation, this website is now a part of Patient Advocate Foundation and remains active during our website transition.
Where to find information during our transition:
- About the merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
Fewer than 1% of clinical trials in the United States include transgender or nonbinary patients. An article in MSN highlights the results of a PAN survey that LGBTQ+ individuals and people of color respondents have a positive view of clinical trials and a strong willingness to participate—but are not being invited to participate by clinicians.
PAN’s Opening Doors to Clinical Trials initiative is mentioned in the article. Through clinical trial education, a TrialFinder tool, and the support of ComPANion Access Navigators, real people available by phone to help navigate clinical trials, PAN’s clinical trials initiative aims to help people overcome barriers to participation.